Director/PDMR Shareholding
January 25 2011 - 11:17AM
UK Regulatory
TIDMBII
25 January 2011
BIOCOMPATIBLES INTERNATIONAL PLC
(the `Company' or `Biocompatibles')
Exercise of options under the Biocompatibles International Group plc Executive
Share Options Scheme 1995 and the Biocompatibles International Performance
Share Plan
Biocompatibles International plc announced on 24 January 2011 that at the first
of the two court hearings required as part of the Scheme, the Court sanctioned
the Scheme under Part 26 of the Companies Act 2006.
As a result of the court sanction, all outstanding Options under the 1995
Executive Scheme became exercisable and the following Directors entered into
transactions in the Company's Ordinary shares of 21 53/94 pence each ("shares")
by exercising the following options under the scheme:
Executive Director The Biocompatibles International Group plc Executive Share
Options Scheme 1995
No of Exercise Date of Grant Approved/Unapproved
options price
Crispin Simon 31,250 GBP1.89 22.08.2001 Unapproved
Crispin Simon 31,250 GBP1.89 22.08.2001 Unapproved Super
Peter Stratford 30,000 GBP0.59 24.09.2001 Unapproved
Additionally, as a result of the court sanction, all previously unvested awards
under the Performance Share Plan have now vested in respect of all the
Biocompatibles shares over which they subsist; and the following Directors
entered into transactions in the Company's Ordinary shares of 21 53/94 pence
each ("shares") by exercising the following awards under the Performance Share
Plan:
Executive Director The Biocompatibles International Performance Share
Plan
No of shares subject to the award Date of award
Crispin Simon 130,000 20.09.2007
Crispin Simon 109,000 01.10.2008
Crispin Simon 85,000 11.09.2009
Ian Ardill 75,000 20.09.2007
Ian Ardill 63,000 01.10.2008
Ian Ardill 50,000 11.09.2009
Peter Stratford 75,000 20.09.2007
Peter Stratford 63,000 01.10.2008
Peter Stratford 50,000 11.09.2009
John Sylvester 75,000 20.09.2007
John Sylvester 63,000 01.10.2008
John Sylvester 50,000 11.09.2009
Crispin Simon
As a result of these exercises, Mr Simon is deemed to be interested in 667,678
shares, representing 1.63% of the Company's issued share capital as of the date
of this notification.
Ian Ardill
As a result of these exercises, Mr Ardill is deemed to be interested in 265,586
shares, representing 0.65% of the Company's issued share capital as of the date
of this notification.
Peter Stratford
As a result of these exercises, Mr Stratford is deemed to be interested in
254,111 shares, representing 0.62% of the Company's issued share capital as of
the date of this notification.
John Sylvester
As a result of these exercises, Mr Sylvester is deemed to be interested in
223,275 shares, representing 0.54% of the Company's issued share capital as of
the date of this notification.
The above notifications are made in accordance with DTR 3.1.4R(1).
- ends -
Contact:
Biocompatibles Tel: +44 (0)1257 732645
Ian Ardill, Finance Director
Lygia Jones, Assistant Company Secretary
Dealing Disclosure Requirements
Following the announcement made on Monday, 20 September 2010 that the Company
is in an offer period for the purposes of the Takeover Code, the Company is
required to restate the following:
Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of
any class of relevant securities of an offeree company or of any paper offeror
(being any offeror other than an offeror in respect of which it has been
announced that its offer is, or is likely to be, solely in cash) must make an
Opening Position Disclosure following the commencement of the offer period and,
if later, following the announcement in which any paper offeror is first
identified. An Opening Position Disclosure must contain details of the person's
interests and short positions in, and rights to subscribe for, any relevant
securities of each of (i) the offeree company and (ii) any paper offeror(s). An
Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be
made by no later than 3.30 pm (London time) on the 10th business day following
the commencement of the offer period and, if appropriate, by no later than 3.30
pm (London time) on the 10th business day following the announcement in which
any paper offeror is first identified. Relevant persons who deal in the
relevant securities of the offeree company or of a paper offeror prior to the
deadline for making an Opening Position Disclosure must instead make a Dealing
Disclosure.
Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1%
or more of any class of relevant securities of the offeree company or of any
paper offeror must make a Dealing Disclosure if the person deals in any
relevant securities of the offeree company or of any paper offeror. A Dealing
Disclosure must contain details of the dealing concerned and of the person's
interests and short positions in, and rights to subscribe for, any relevant
securities of each of (i) the offeree company and (ii) any paper offeror, save
to the extent that these details have previously been disclosed under Rule 8. A
Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no
later than 3.30 pm (London time) on the business day following the date of the
relevant dealing. If two or more persons act together pursuant to an agreement
or understanding, whether formal or informal, to acquire or control an interest
in relevant securities of an offeree company or a paper offeror, they will be
deemed to be a single person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree company and by
any offeror and Dealing Disclosures must also be made by the offeree company,
by any offeror and by any persons acting in concert with any of them (see Rules
8.1, 8.2 and 8.4).
Details of the offeree and offeror companies in respect of whose relevant
securities Opening Position Disclosures and Dealing Disclosures must be made
can be found in the Disclosure Table on the Takeover Panel's website at
www.thetakeoverpanel.org.uk, including details of the number of relevant
securities in issue, when the offer period commenced and when any offeror was
first identified. If you are in any doubt as to whether you are required to
make an Opening Position Disclosure or a Dealing Disclosure, you should contact
the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.
END
Biocompatibles (LSE:BII)
Historical Stock Chart
From Oct 2024 to Oct 2024
Biocompatibles (LSE:BII)
Historical Stock Chart
From Oct 2023 to Oct 2024